ライフサイエンスコーパス: transforming growth factor alpha

1 owth factor, keratinocyte growth factor, and transforming growth factor alpha).

2 ctor, glial-derived neurotrophic factor, and transforming growth factor-alpha).

3 ation with either epidermal growth factor or transforming growth factor alpha.

4 heparin-binding epidermal growth factor and transforming growth factor alpha.

5 EGFR) pathway due to increased expression of transforming growth factor alpha.

6 7, including tumor necrosis factor alpha and transforming growth factor alpha.

7 the expression of mRNAs for amphiregulin and transforming growth factor alpha.

8 B1, p-ErbB2, p-Erk1/2, p-Akt, cyclin D1, and transforming growth factor alpha.

9 se of many transmembrane proteins, including transforming growth factor-alpha.

10 24 h with a potent fetal hepatocyte mitogen, transforming growth factor-alpha.

11 phatase 5 and positive feedback by autocrine transforming growth factor-alpha.

12 The EGFR ligands EGF (100 ng ml(-1)), transforming growth factor alpha (0.4 ng ml(-1)) and hep

13 ased mRNA levels of EGFR (6.0 +/- 1.7-fold), transforming growth factor-alpha (14.4 +/- 5.0-fold), he

14 Azoxymethane significantly induced pro-transforming growth factor-alpha (6.4+/-1.3-fold) and in

15 mRNAs for interleukin 1alpha (IL-1alpha) and transforming growth factor alpha (8 of 8); transforming

16 DAM17 as the major convertase of epiregulin, transforming growth factor alpha, amphiregulin, and hepa

17 gens, such as epidermal growth factor (EGF), transforming growth factor alpha, amphiregulin, and hepa

18 s of plasma gastrin; increased expression of transforming growth factor-alpha, amphiregulin, and gast

19 in the neck and base, secrete HCl as well as transforming growth factor-alpha, amphiregulin, heparin-

20 e of additional EGF receptor (EGFR) ligands (transforming growth factor-alpha, amphiregulin, hereguli

21 Transforming growth factor -alpha and insulin-like growt

22 These cells express both transforming growth factor alpha and amphiregulin and re

23 wever, calcium influx-stimulated shedding of transforming growth factor alpha and amphiregulin does n

24 ion of conditioned medium with antibodies to transforming growth factor alpha and EGF significantly i

25 Autocrine production of transforming growth factor alpha and overexpression of t

26 orted E2-inducible autocrine growth factors, transforming growth factor alpha and stromal cell-derive

27 cells secrete a number of factors including transforming growth factor alpha and tenascin, which whe

28 ently into skin wounds and that they express transforming growth factor-alpha and -beta 1 mRNAs and p

29 factor such as hepatocyte growth factor and transforming growth factor-alpha and -beta.

30 2 prototype experimental models, i.e., c-myc/transforming growth factor-alpha and c-myc/E2F-1 mice, f

31 owth factor receptor (EGFR) and its ligands, transforming growth factor-alpha and EGF.

32 unsuspected autocrine circuits activated by transforming growth factor-alpha and interleukin-1alpha,

33 e rat gastric epithelial cell line RGM1 with transforming growth factor-alpha and interleukin-1beta l

34 We show that constitutive expression of transforming growth factor-alpha and its subsequent cons

35 progesterone or epidermal growth factor plus transforming growth factor-alpha and p53 responses to ga

36 of autocrine growth factor ligands, such as (transforming growth factor alpha) and TNF-alpha, followi

37 Mice lacking epidermal growth factor (EGF), transforming growth factor alpha, and amphiregulin were

38 factor receptor superfamily member 9, CCL23, transforming growth factor alpha, and CXCL13.

39 s of heparin-binding EGF-like growth factor, transforming growth factor-alpha, and amphiregulin mRNA

40 ent glands expressed increased amphiregulin, transforming growth factor-alpha, and betacellulin mRNA

41 ansforming growth factor-alpha, E2F-1, c-myc/transforming growth factor-alpha, and c-myc/E2F-1 mice.

42 ssion of vascular endothelial growth factor, transforming growth factor-alpha, and cyclin D1.

43 ine gastrins, insulin-like growth factor-II, transforming growth factor-alpha, and endocrine gastrins

44 ncluding vascular endothelial growth factor, transforming growth factor-alpha, and erythropoietin.

45 t genes, vascular endothelial growth factor, transforming growth factor-alpha, and Glut-1 was abrogat

46 ifferent polypeptide ligands, including EGF, transforming growth factor-alpha, and heparin-binding EG

47 Addition of basic fibroblast growth factor, transforming growth factor-alpha, and hepatocyte growth

48 n in response to epidermal growth factor and transforming growth factor-alpha, and increased phosphor

49 a result of the additive effects of hypoxia, transforming growth factor-alpha, and interleukin-1beta.

50 regulation of epidermal growth factor (EGF), transforming growth factor-alpha, and nuclear oncogenes

51 tin-1, angiogenin, hepatocyte growth factor, transforming growth factor-alpha, and tumor necrosis fac

52 nectin 1; keratins 14, 18, and 19; vimentin; transforming growth factor alpha; and autocrine motility

53 EGFR ligands such as transforming growth factor alpha are also overexpressed

54 and its ligands, epidermal growth factor and transforming growth factor alpha, as well as several tum

55 arious RAS mutant colon carcinoma lines, the transforming growth factor-alpha autocrine loop differen

56 Whereas HGF, EGF, transforming growth factor alpha, basic fibroblast growt

57 stimulus for fibroblasts than natural EGF or transforming growth factor alpha because of its altered

58 mouse mammary tumor virus (MMTV)/Neu + MMTV/transforming growth factor alpha bigenic mice.

59 sidues for epidermal growth factor (EGF) and transforming growth factor alpha binding to the EGF rece

60 fibroblast growth factor 2, IL-7, IL-15, and transforming growth factor alpha) but lower levels of th

61 We find that the oncogenes c-myc and transforming growth factor alpha, but not simian virus 4

62 exogenous epidermal growth factor (EGF) and transforming growth factor-alpha, but not by isoforms of

63 Endogenous transforming growth factor-alpha, but not epidermal grow

64 wth factor-induced shedding of transmembrane transforming growth factor-alpha by TACE.

65 transfecting colon cancer cells with a human transforming growth factor-alpha cDNA (a ligand for EGFR

66 growth factor receptor-1, p70 S6 kinase, and transforming growth factor alpha compared with nonrespon

67 Among these GFs, transforming growth factor-alpha [corrected] showed the

68 to basic fibroblast growth factor, IL-7, and transforming growth factor alpha, coupling strength and

69 ing metaplasia (SPEM), amphiregulin (AR) and transforming growth factor-alpha-deficient mice and thei

70 Although loss of transforming growth factor-alpha did not influence the i

71 carcinoma nodules that develop in the c-myc/transforming growth factor-alpha-driven and the hepatiti

72 nic models of liver cancer, including c-myc, transforming growth factor-alpha, E2F-1, c-myc/transform

73 ther promoted the expression and activity of transforming growth factor alpha, EGFR and AP1 transcrip

74 Interruption of transforming growth factor alpha-EGFR autocrine regulati

75 nding to tyrosine kinase receptors including transforming growth factor-alpha, epidermal growth facto

76 EGFR epithelial distribution and transforming growth factor alpha expression were also al

77 n oogenesis, Gurken protein, a member of the transforming growth factor alpha family, is produced by

78 TIMP-2 neither altered the release of transforming growth factor alpha from the cell surface,

79 CK cells after administration of AR, but not transforming growth factor-alpha, further supporting a s

80 formed a meta-analysis of the association of transforming growth factor alpha gene (TGFA) polymorphis

81 umors from mice bitransgenic for the neu and transforming growth factor-alpha genes (both driven by t

82 ce other EGF-related peptides including EGF, transforming growth factor alpha, heparin-binding EGF-li

83 ates, including tumor necrosis factor alpha, transforming growth factor alpha, heparin-binding epider

84 epidermal growth factor (EGF) receptor, EGF, transforming growth factor-alpha, heparin-binding EGF-li

85 v-rasHa (HK1.ras), v-fos (HK1.fos), or human transforming growth factor alpha+HK1.TGFalpha) exclusive

86 tumor necrosis factor-alpha, IFN-gamma, and transforming growth factor-alpha in cultured keratinocyt

87 , granulocyte colony-stimulating factor, and transforming growth factor-alpha in response to gluten t

88 important in distinguishing between EGF and transforming growth factor-alpha in their recognition by

89 ound by several activating ligands including Transforming Growth Factor-alpha in vertebrates, and its

90 207%, and prostaglandin E2 by 240%, whereas transforming growth factor alpha increased by 225% and v

91 TNF-alpha, but not transforming growth factor-alpha, induced mucus producti

92 sted, two [epidermal growth factor (EGF) and transforming growth factor-alpha] induced expression of

93 ion/repair, whereas epidermal growth factor, transforming growth factor alpha, insulin, IGF-1, and IG

94 ession of a wide variety of genes, including transforming growth factor-alpha, insulin-like growth fa

95 cyte growth factor, epidermal growth factor, transforming growth factor-alpha, interleukin-6, tumor n

96 gnalling pathway, which includes a localised transforming growth factor-alpha like molecule, Gurken,

97 nds, Gurken (Grk) and Spitz (Spi), which are transforming growth factor alpha-like proteins, Vn has b

98 ffects the accumulation of Gurken protein, a transforming growth factor alpha-like signaling molecule

99 kpoint activity regulates translation of the transforming growth-factor-alpha-like Gurken signaling m

100 arin resulted in a significant inhibition of transforming growth factor alpha-mediated activation of

101 epithelial chloride secretion as a result of transforming growth factor-alpha-mediated EGFR transacti

102 enomic instability (exemplified by the c-myc/transforming growth factor-alpha mouse) and activation o

103 We characterized the novel NRL-transforming growth factor alpha (NRL-TGFalpha) transgen

104 In addition, PGE(2), in collaboration with transforming growth factor-alpha or K-Ras oncogene, syne

105 kin that is distinct from that of transgenic transforming growth factor-alpha or other cytokines, and

106 Neither intratumoral EGFR, transforming growth factor-alpha or phosphorylated Akt k

107 ting ligands [epidermal growth factor (EGF), transforming growth factor alpha, or heparin-binding EGF

108 amine and somatostatin), and autocrine (e.g. transforming growth factor-alpha) pathways.

109 heparin-binding EGF-like growth factor, and transforming growth factor-alpha phosphorylated both rec

110 d epithelial cells significantly upregulated transforming growth factor alpha precursor expression, s

111 In contrast to human transforming growth factor-alpha precursor (proTGFalpha)

112 bstrates of the general shedding system, the transforming growth factor-alpha precursor, pro-TGF-alph

113 e, pH, bicarbonate, epidermal growth factor, transforming growth factor alpha, prostaglandin E2, muci

114 ory cytokines, such as interleukin-1 beta or transforming growth factor alpha, protects carcinomas fr

115 nzyme (ADAM17), which cleaves membrane-bound transforming growth factor alpha (proTGF-alpha) and rele

116 tion in direct proportion to their effect on transforming growth factor alpha release.

117 M1-IT4 cells with epidermal growth factor or transforming growth factor alpha resulted in increased c

118 e tumors, basic fibroblast growth factor and transforming growth factor alpha RNA expression was dete

119 the embryonic axes is initiated by Gurken, a transforming growth factor alpha signal from the oocyte

120 MDLC with a toll-like receptor 2 agonist or transforming growth factor-alpha significantly increases

121 n probe, whereas epidermal growth factor and transforming growth factor-alpha stimulate the expressio

122 Fyn, and Lyn were expressed and activated by transforming growth factor-alpha stimulation in all four

123 Tumor necrosis factor-alpha (TNF-alpha) or transforming growth factor-alpha stimulation of human ep

124 ived from MPM patients express both EGFR and transforming growth factor alpha, suggesting an autocrin

125 Recently, we have shown that PGE(2) and transforming growth factor-alpha synergistically induces

126 contrast, at least one oncogene combination, transforming growth factor alpha/T-antigen, was sufficie

127 4-Hydroxytamoxifen is a full agonist at a transforming growth factor alpha target gene in situ in

128 o MDA-MB-231 cells and the activation of the transforming growth factor alpha target gene in situ tha

129 The epidermal growth factor receptor ligands transforming growth factor alpha (TGF alpha) and amphire

130 Aberrant transcriptional regulation of transforming growth factor alpha (TGF alpha) appears to

131 An increased production of transforming growth factor alpha (TGF alpha) in the hypo

132 Transforming growth factor alpha (TGF alpha) interacts w

133 have examined mRNAs for Kgf receptor (KgfR), transforming growth factor alpha (Tgf alpha), epidermal

134 locks completely the binding of both EGF and transforming growth factor alpha (TGF-a) to various EGFr

135 eated with HGF, epidermal growth factor, and transforming growth factor alpha (TGF-alpha) alpha showe

136 In these cells, although transforming growth factor alpha (TGF-alpha) and epiderm

137 Transforming growth factor alpha (TGF-alpha) and epiderm

138 oma of the head and neck (SCCHN) overexpress transforming growth factor alpha (TGF-alpha) and its rec

139 wing that expression of the genes coding for transforming growth factor alpha (TGF-alpha) and platele

140 kinase (MAPK) pathway activation by E2, and transforming growth factor alpha (TGF-alpha) as a positi

141 ivation in part via extracellular release of transforming growth factor alpha (TGF-alpha) by matrix m

142 hepatocyte growth factor (HGF), induction of transforming growth factor alpha (TGF-alpha) expression,

143 ovel assay in vitro was used to activate the transforming growth factor alpha (TGF-alpha) gene in sit

144 uced by epidermal growth factor (EGF) and by transforming growth factor alpha (TGF-alpha) in NIH3T3 c

145 ently shown that overexpression of c-myc and transforming growth factor alpha (TGF-alpha) in the live

146 Transgenic mice with ectopic expression of transforming growth factor alpha (TGF-alpha) in the panc

147 CCh caused the basolateral release of transforming growth factor alpha (TGF-alpha) into T(84)

148 There is indirect evidence that transforming growth factor alpha (TGF-alpha) is an impor

149 Transforming growth factor alpha (TGF-alpha) is biosynth

150 by determining their ability to up-regulate transforming growth factor alpha (TGF-alpha) mRNA in MDA

151 er due to expression in mammary epithelia of transforming growth factor alpha (TGF-alpha) or c-myc.

152 Macrophages secrete transforming growth factor alpha (TGF-alpha) to trigger

153 MEK activity in vitro in immortalized murine transforming growth factor alpha (TGF-alpha) transgenic

154 Transforming growth factor alpha (TGF-alpha) was ectopic

155 expressed the epidermal growth factor (EGF), transforming growth factor alpha (TGF-alpha), EGF recept

156 AG1478 was able to prevent TCDD-, EGF-, and transforming growth factor alpha (TGF-alpha)-dependent c

157 ce that miR-8-positive glia express Spitz, a transforming growth factor alpha (TGF-alpha)-like ligand

158 contains elevated levels of the EGFR ligand transforming growth factor alpha (TGF-alpha).

159 HGF receptor and transforming growth factor alpha (TGF-alpha)/epidermal g

160 One candidate is the hepatocyte mitogen transforming growth factor alpha (TGF-alpha); in HBV-inf

161 idermal growth factor (EGF) family including transforming growth factor-alpha (TGF alpha) and EGF are

162 Soluble forms of transforming growth factor-alpha (TGF alpha) are derived

163 al growth factor receptor (EGFR), its ligand transforming growth factor-alpha (TGF alpha), the downst

164 In vitro, EBD cells secrete transforming growth factor-alpha (TGF-alpha) and brain-d

165 wn to abrogate transcriptional activation of transforming growth factor-alpha (TGF-alpha) and epiderm

166 Among the various growth factors examined, transforming growth factor-alpha (TGF-alpha) and insulin

167 been shown to stimulate autocrine release of transforming growth factor-alpha (TGF-alpha) and interle

168 imary astrocytes requires stimulation of the transforming growth factor-alpha (TGF-alpha) and of the

169 okines were increased, whereas the levels of transforming growth factor-alpha (TGF-alpha) and platele

170 Transforming growth factor-alpha (TGF-alpha) and related

171 In a systematic screen, we identified transforming growth factor-alpha (TGF-alpha) as a likely

172 investigation demonstrated that cleavage of transforming growth factor-alpha (TGF-alpha) by matrix m

173 Recently, we have shown that autocrine transforming growth factor-alpha (TGF-alpha) controls th

174 HGF, EGF, and transforming growth factor-alpha (TGF-alpha) enhance the

175 eptor (EGFR) and ErbB2 by elevated autocrine transforming growth factor-alpha (TGF-alpha) expression

176 We have previously reported that the human transforming growth factor-alpha (TGF-alpha) gene encode

177 The human transforming growth factor-alpha (TGF-alpha) gene is tho

178 By inhibiting the expression of the transforming growth factor-alpha (TGF-alpha) gene produc

179 induced by epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha) has been st

180 Despite constitutive expression of autocrine transforming growth factor-alpha (TGF-alpha) in growth f

181 were assessed in transgenic mice expressing transforming growth factor-alpha (TGF-alpha) in pulmonar

182 Transforming growth factor-alpha (TGF-alpha) is a candid

183 Transforming growth factor-alpha (TGF-alpha) is a member

184 o determine the molecular mechanism by which transforming growth factor-alpha (TGF-alpha) is a more p

185 The level of activation of this receptor by transforming growth factor-alpha (TGF-alpha) is controll

186 Transforming growth factor-alpha (TGF-alpha) is synthesi

187 Transforming growth factor-alpha (TGF-alpha) is the majo

188 binding of epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha) ligands.

189 The estrogen-induced expression of the transforming growth factor-alpha (TGF-alpha) mRNA transc

190 ibition of matrix metalloproteinases (MMPs), transforming growth factor-alpha (TGF-alpha) or c-Src bl

191 xpression of wild-type EGFR ligands, such as transforming growth factor-alpha (TGF-alpha) or heparin-

192 n of insulin-like growth factor (IGF)-II and transforming growth factor-alpha (TGF-alpha) over IGF-I

193 erting enzyme (TACE/ADAM17) is a physiologic transforming growth factor-alpha (TGF-alpha) sheddase, a

194 Here, we investigate the regulation of transforming growth factor-alpha (TGF-alpha) shedding by

195 rogen receptor modulator, is an agonist at a transforming growth factor-alpha (TGF-alpha) target gene

196 t mice possess a defect in the production of transforming growth factor-alpha (TGF-alpha) that leads

197 Transforming growth factor-alpha (TGF-alpha) transduces

198 Transforming growth factor-alpha (TGF-alpha) treatment p

199 ) c-kit, hepatocyte growth factor (HGF), and transforming growth factor-alpha (TGF-alpha) was observe

200 line of double transgenic mice that express transforming growth factor-alpha (TGF-alpha), a liver mi

201 Transforming growth factor-alpha (TGF-alpha), a potent e

202 th polymorphisms in the gene (TGFA) encoding transforming growth factor-alpha (TGF-alpha), an epiderm

203 insulin-like growth factor-1 (IGF-1), IGF-2, transforming growth factor-alpha (TGF-alpha), and epider

204 tor (EGF) family hormones amphiregulin (AR), transforming growth factor-alpha (TGF-alpha), and hepari

205 rowth factor (EGF) receptor ligands, EGF and transforming growth factor-alpha (TGF-alpha), but not by

206 hat recognize epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), EGF recept

207 We have examined the distribution of transforming growth factor-alpha (TGF-alpha), epidermal

208 ung disease induced by the overexpression of transforming growth factor-alpha (TGF-alpha), establishe

209 ulin 1-beta (NRG1-beta), betacellulin (BTC), transforming growth factor-alpha (TGF-alpha), heparin bi

210 nd indirectly, via the sequential release of transforming growth factor-alpha (TGF-alpha), interleuki

211 rowth factor (HB-EGF), neuregulin (NRG), and transforming growth factor-alpha (TGF-alpha), is importa

212 eration with the well-characterized oncogene transforming growth factor-alpha (TGF-alpha), PRL induce

213 f the integral membrane precursor to soluble transforming growth factor-alpha (TGF-alpha), pro-TGF-al

214 A variety of transmembrane proteins, such as transforming growth factor-alpha (TGF-alpha), tumor necr

215 s ligands, epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha).

216 sponses to epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha).

217 lpha, resulting in enhanced transcription of transforming growth factor-alpha (TGF-alpha).

218 by increasing selective autocrine release of transforming growth factor-alpha (TGF-alpha).

219 R and ERK1/2 phosphorylation was mediated by transforming growth factor-alpha (TGF-alpha).

220 colon carcinoma cells are stimulated by the transforming growth factor-alpha (TGF-alpha)/epidermal g

221 enerated transgenic mice that express either transforming growth factor (alpha) (TGF(alpha)) or epide

222 are applied to test for association between transforming growth factor alpha (TGFA) gene and cleft p

223 Transforming growth factor alpha (TGFA) is a well-charac

224 Transforming growth factor-alpha (TGFA) has been propose

225 deleted fibroblasts had higher expression of transforming growth factor-alpha (Tgfa) mRNA and secrete

226 onment interaction between maternal smoking, transforming growth factor-alpha (TGFa), and clefting ha

227 ough the epidermal growth factor receptor by transforming growth factor alpha (TGFalpha) and found th

228 The growth factor transforming growth factor alpha (TGFalpha) and the nucl

229 Recently, we showed that autocrine transforming growth factor alpha (TGFalpha) controls the

230 (EGFR) signaling pathway due to the enhanced transforming growth factor alpha (TGFalpha) expression p

231 in (AREG), heparin-binding EGF (HB-EGF), and transforming growth factor alpha (TGFalpha) from tumor c

232 y of 351 mutant ERs and antiestrogens at the transforming growth factor alpha (TGFalpha) gene in situ

233 of a neutralizing monoclonal antibody versus transforming growth factor alpha (TGFalpha) had no effec

234 ative, neurogenic, and behavioral effects of transforming growth factor alpha (TGFalpha) in a 6-OHDA

235 s when co-expressed with the potent oncogene transforming growth factor alpha (TGFalpha) in bitransge

236 (HGF/SF), epidermal growth factor (EGF), and transforming growth factor alpha (TGFalpha) in the prese

237 onal agent-based approach with an integrated transforming growth factor alpha (TGFalpha) induced EGFR

238 nigra dopaminergic neurons and infusions of transforming growth factor alpha (TGFalpha) into forebra

239 Transforming growth factor alpha (TGFalpha) is a potent

240 Transforming growth factor alpha (TGFalpha) is a princip

241 Autocrine transforming growth factor alpha (TGFalpha) is an import

242 Transforming growth factor alpha (TGFalpha) is widely ex

243 Increase of intramucosal transforming growth factor alpha (TGFalpha) levels in th

244 ously validated assay using the induction of transforming growth factor alpha (TGFalpha) mRNA in situ

245 ith an ERE3-luciferase reporter, and second, transforming growth factor alpha (TGFalpha) mRNA was use

246 r sensory epithelia, as does the infusion of transforming growth factor alpha (TGFalpha) plus insulin

247 Activation of these receptors by transforming growth factor alpha (TGFalpha) results in p

248 ave shown that intrathecal administration of transforming growth factor alpha (TGFalpha) to the contu

249 The mitogenic effects of insulin and transforming growth factor alpha (TGFalpha) were assayed

250 proTGFalpha, the transmembrane precursor of transforming growth factor alpha (TGFalpha), as a model

251 r epithelial cells constitutively expressing transforming growth factor alpha (TGFalpha), c-Met is co

252 or receptors (EGF-R) by its ligands, EGF and transforming growth factor alpha (TGFalpha), causes MUC5

253 t cancers, that for c-erbB-2 (HER-2) and for transforming growth factor alpha (TGFalpha), have been c

254 GF I contained transforming growth factor alpha (TGFalpha), insulin-lik

255 ransfected RIE-1 cells, as well as exogenous transforming growth factor alpha (TGFalpha), promoted mo

256 mutant EGFR signaling or lack of its ligand transforming growth factor alpha (TGFalpha), suggesting

257 17 proteolytic targets, amphiregulin (AREG), transforming growth factor alpha (TGFalpha), syndecan-1

258 or without epidermal growth factor (EGF) or transforming growth factor alpha (TGFalpha), which are k

259 vivo, we assessed the effects of estrogen on transforming growth factor alpha (TGFalpha)- and prolact

260 The activation of transforming growth factor alpha (TGFalpha)-erbB-1 and n

261 ets, we investigated secreted molecules from transforming growth factor alpha (TGFalpha)-stimulated h

262 e dose-dependent shedding of the EGFR ligand transforming growth factor alpha (TGFalpha).

263 as basic fibroblast growth factor (bFGF) or transforming growth factor alpha (TGFalpha).

264 The transforming growth factor alpha (TGFalpha)/epidermal gr

265 ity of hepatocytes to growth factors such as transforming growth factor alpha (TGFalpha); however, th

266 Transforming growth factor-alpha (TGFalpha) and fibrobla

267 ligands, epidermal growth factor (EGF), and transforming growth factor-alpha (TGFalpha) elicit diffe

268 f shedding epidermal growth factor (EGF) and transforming growth factor-alpha (TGFalpha) from the pla

269 Transforming growth factor-alpha (TGFalpha) gene transcr

270 t, a signal from the oocyte (Gurken (Grk), a transforming growth factor-alpha (TGFalpha) homolog) is

271 We demonstrate that transforming growth factor-alpha (TGFalpha) induces cycl

272 Transforming growth factor-alpha (TGFalpha) is a ligand

273 Here, we report that transforming growth factor-alpha (TGFalpha) may regulate

274 Sprague-Dawley rats expressing either human transforming growth factor-alpha (TGFalpha) or simian vi

275 t mammary branching morphogenesis induced by transforming growth factor-alpha (TGFalpha) requires PI3

276 ling induced by over-expression of c-myc and transforming growth factor-alpha (TGFalpha) transgenes i

277 f human BDNF, rat CNTF, human FGF2, or human transforming growth factor-alpha (TGFalpha), and immunoh

278 gainst potential EGFR ligands suggested that transforming growth factor-alpha (TGFalpha), but not the

279 he erbB receptor-activating ligands, such as transforming growth factor-alpha (TGFalpha), NRG1alpha,

280 t the EGFR ligands EGF, heparin-binding-EGF, transforming growth factor-alpha (TGFalpha), or amphireg

281 ed by a variety of ligands including EGF and transforming growth factor-alpha (TGFalpha), whereas no

282 m samples were measured for amphiregulin and transforming growth factor-alpha (TGFalpha).

283 eptor, the L-selectin adhesion molecule, and transforming growth factor-alpha (TGFalpha).

284 sion of epidermal growth factor receptor and transforming growth factor-alpha than distant mucosa.

285 e the binding of epidermal growth factor and transforming growth factor-alpha to ErbB1.

286 NIKS cells express steady-state levels of transforming growth factor-alpha, transforming growth fa

287 Analysis of whey acidic protein-transforming growth factor-alpha transgenic mouse mammar

288 The c-myc/transforming growth factor-alpha tumors displayed extens

289 ivated EGFR, the release of amphiregulin and transforming growth factor alpha, two ligands of the EGF

290 In epidermis of transgenic mice expressing transforming growth factor alpha under control of the ke

291 ADM in response to transforming growth factor alpha was also suppressed in

292 phorylation of mt25, whereas the response to transforming growth factor-alpha was undetectable.

293 wo EGFR ligands, epidermal growth factor and transforming growth factor-alpha, we found that activate

294 actor 2, platelet-derived growth factor, and transforming growth factor alpha were altered due to lac

295 n-like growth factor-I (IGF-I), insulin, and transforming growth factor-alpha were assayed in organo-

296 EGF and transforming growth factor-alpha were increased at the e

297 dermal growth factor-like growth factor, and transforming growth factor-alpha) were up-regulated in t

298 andard medium or in medium supplemented with transforming growth factor-alpha when compared with cont

299 activation of ERK activity induced by either transforming growth factor-alpha, which links extracellu

300 ha accumulation, which induces expression of transforming growth factor alpha, with consequent activa